Associated mortality risk of atypical antipsychotic medication in individuals with dementia
- PMID: 35317344
- PMCID: PMC8900589
- DOI: 10.5498/wjp.v12.i2.298
Associated mortality risk of atypical antipsychotic medication in individuals with dementia
Abstract
Background: Antipsychotic medications such as risperidone, olanzapine and aripiprazole are used to treat psychological and behavioural symptoms among dementia patients. Current evidence indicate prescription rates for antipsychotics vary and wider consensus to evaluate clinical epidemiological outcomes is limited.
Aim: To investigate the potential impact of atypical antipsychotics on the mortality of patients with dementia.
Methods: A retrospective clinical cohort study was developed to review United Kingdom Clinical Record Interactive Search system based data between January 1, 2013 to December 31, 2017. A descriptive statistical method was used to analyse the data. Mini Mental State Examination (MMSE) scores were used to assess the severity and stage of disease progression. A cox proportional hazards model was developed to evaluate the relationship between survival following diagnosis and other variables.
Results: A total of 1692 patients were identified using natural language processing of which, 587 were prescribed olanzapine, quetiapine or risperidone (common group) whilst 893 (control group) were not prescribed any antipsychotics. Patients prescribed olanzapine showed an increased risk of death [hazard ratio (HR) = 1.32; 95% confidence interval (CI): 1.08-1.60; P < 0.01], as did those with risperidone (HR = 1.35; 95%CI: 1.18-1.54; P < 0.001). Patients prescribed quetiapine showed no significant association (HR = 1.09; 95%CI: 0.90-1.34; P = 0.38). Factors associated with a lower risk of death were: High MMSE score at diagnosis (HR = 0.72; 95%CI: 0.62-0.83; P < 0.001), identifying as female (HR = 0.73; 95%CI: 0.64-0.82; P < 0.001), and being of a White-British ethnic group (HR = 0.82; 95%CI: 0.72-0.94; P < 0.01).
Conclusion: A significant mortality risk was identified among those prescribed olanzapine and risperidone which contradicts previous findings although the study designs used were different. Comprehensive research should be conducted to better assess clinical epidemiological outcomes associated with diagnosis and therapies to improve clinical management of these patients.
Keywords: Alzheimer’s disease; Antipsychotics; Dementia; Frontotemporal dementia; Lewy bodies; Mortality; Parkinson’s and mixed; Vascular.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: Phiri P has received other, educational from Queen Mary University of London, Stanford University School of Medicine and other from John Wiley and Blackwell, outside the submitted work. Rathod S reports other from Janssen, Otsuka and Lundbeck outside the submitted work. All other authors report no conflict of interest.
Figures
Similar articles
-
Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics.Am Health Drug Benefits. 2012 Sep;5(6):379-86. Am Health Drug Benefits. 2012. PMID: 24991334 Free PMC article.
-
Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?J Am Geriatr Soc. 2010 Jun;58(6):1027-34. doi: 10.1111/j.1532-5415.2010.02873.x. Epub 2010 May 7. J Am Geriatr Soc. 2010. PMID: 20487081
-
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.JAMA Psychiatry. 2015 May;72(5):438-45. doi: 10.1001/jamapsychiatry.2014.3018. JAMA Psychiatry. 2015. PMID: 25786075 Free PMC article.
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
Cited by
-
Protocol for a usability and pilot implementation study of a digital medical device to assess pain in non-verbal people with dementia in Portuguese residential care facilities.Digit Health. 2025 Feb 13;11:20552076241311326. doi: 10.1177/20552076241311326. eCollection 2025 Jan-Dec. Digit Health. 2025. PMID: 39949844 Free PMC article.
-
Akrivia Health Database-deep patient characterisation using a secondary mental healthcare dataset in England and Wales: cohort profile.BMJ Open. 2024 Oct 17;14(10):e088166. doi: 10.1136/bmjopen-2024-088166. BMJ Open. 2024. PMID: 39419624 Free PMC article.
-
Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy.Alzheimers Dement (Amst). 2025 Feb 11;17(1):e70082. doi: 10.1002/dad2.70082. eCollection 2025 Jan-Mar. Alzheimers Dement (Amst). 2025. PMID: 39935888 Free PMC article. Review.
-
Underlying disease may increase mortality risk in users of atypical antipsychotics.World J Psychiatry. 2022 Aug 19;12(8):1112-1114. doi: 10.5498/wjp.v12.i8.1112. eCollection 2022 Aug 19. World J Psychiatry. 2022. PMID: 36158300 Free PMC article.
References
-
- Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R Silver Network Home Care Study Group. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci. 2005;60:622–626. - PubMed
-
- Hwang YJ, Dixon SN, Reiss JP, Wald R, Parikh CR, Gandhi S, Shariff SZ, Pannu N, Nash DM, Rehman F, Garg AX. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med. 2014;161:242–248. - PubMed
-
- Fraser LA, Liu K, Naylor KL, Hwang YJ, Dixon SN, Shariff SZ, Garg AX. Falls and fractures with atypical antipsychotic medication use: a population-based cohort study. JAMA Intern Med. 2015;175:450–452. - PubMed
-
- Banerjee S. The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services. [cited 27 May 2021]. Available from: http://psychrights.org/Research/Digest/NLPs/BanerjeeReportOnGeriatricNeu... .
LinkOut - more resources
Full Text Sources